DMAC

DMAC Operating Cash Flow (Statement)

-$31.57MTTM · USD

Period ending:

DMAC FY Cash from OperationsUSD
DMAC FY Cash from Operations2004-12-31: -$99.35K2005-12-31: -$831.17K2006-12-31: -$801.16K2007-12-31: -$1.21M2008-12-31: -$1.47M2009-12-31: -$2.15M2010-12-31: -$2.38M2011-12-31: -$3.44M2012-12-31: -$5.48M2013-12-31: -$5.50M2014-12-31: -$3.76M2015-12-31: -$1.37M2016-12-31: -$3.02M2017-12-31: -$3.90M2018-12-31: -$5.70M2019-12-31: -$9.10M2020-12-31: -$9.19M2021-12-31: -$12.25M2022-12-31: -$11.51M2023-12-31: -$18.73M2024-12-31: -$22.08M2025-12-31: -$29.06M$0.00-$29.06M
2004-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

DMAC operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 22 observations from Dec 31, 2004 to Dec 31, 2025.

Diamedica Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-29,062,000
-22,076,000
-18,728,000
-11,511,000
-12,252,000
-9,185,000
-9,102,000
-5,696,000
-3,900,000
-3,023,179
-1,365,931
-3,755,675
-5,502,606
-5,483,825
-3,436,017
-2,376,769
-2,146,707
-1,466,355
-1,213,352
-801,159
-831,166
-99,354

Compare operating cash flow (statement)

All DMAC financial metrics · DMAC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.